Two Israeli medical cannabis companies announced entering a strategic partnership to co-found development and clinical validation of a range of cannabis-based ADHD products.

The two companies, Yom Chai and Kaneh-B, will conduct joint scientific trials in Israel utilizing various cannabinoids to bridge the gap between patients and doctors to bring scientifically-validated products to market.

Scot Albert, CEO of Yom Chai said, “We are excited to be working with Ofer Segal CEO and Yahav Blaicher Co-Founder of Kaneh-B to formulate, manufacture, and distribute world class cannabis-based products to the international marketplace”.

Click here to read the complete article

Mordechai Sones ~ IsraelNationalNews.com

Recent News Articles

Monday October 21

Key Northeastern governors join forces to chart a path to legalizing marijuana - Cannabis News

in Top Stories

by Bruce Kennedy - Editor in Chief

The governors of Pennsylvania, New Jersey, Connecticut, and New York met Thursday for a summit…

982 hits

Monday October 21

UConn Launches Hemp Testing Lab in Response to Industry Need - Cannabis News

in Science

by Bruce Kennedy - Editor in Chief

In response to a rapidly expanding commercial hemp industry driven by interest in products with…

1017 hits

Monday October 21

Slow rollout in marijuana sales costs Maine revenue and jobs - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

Three years after legalizing adult-use marijuana, the state’s still waiting for retail shops. Consultants say…

979 hits

Monday October 21

Chesapeake Bay scientists studying environmental, economic uses for hemp - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

A Gold Rush mentality has erupted across Chesapeake Bay states as the lacy fan-shaped leaves…

1462 hits

Tuesday October 22

Michael J. Fox Parkinson’s Foundation Urges Congress To Pass Three Marijuana Research Bills - Cannabis…

in Activism

by Bruce Kennedy - Editor in Chief

A leading advocacy group that’s dedicated to finding treatment options for Parkinson’s disease is backing…

834 hits